Human Papilloma Virus Vaccination: Recent Trends in Prevalence and Recommendations in India

Megha Snehal Patel; Khyati Mitesh Kakkad; Snehal Vitthalbhai Patel

doi:10.5005/jp-journals-10032-1029

SEARCH WITHIN CONTENT

Online First

Human Papilloma Virus Vaccination: Recent Trends in Prevalence and Recommendations in India

Megha Snehal Patel, Khyati Mitesh Kakkad, Snehal Vitthalbhai Patel

Citation Information : Patel MS, Kakkad KM, Patel SV. Human Papilloma Virus Vaccination: Recent Trends in Prevalence and Recommendations in India. J South Asian Feder Menopause Soc 2014; 2 (1):26-30.

DOI: 10.5005/jp-journals-10032-1029

Published Online: 01-08-2014

ARTICLE
REFERENCES

Abstract

PDF Share

Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol 2012 Jan-Mar;33(1):7-12.
Prevention of cervical cancer-HPV vaccines. Pediatr Infect Dis 2009 July-Sept;1:134-145.
Chapter 1: HPV and cervical cancer burden and assessment of causality. J Natl Cancer Inst Monogr 2003;313.
IAP guide book on immunization 2009-2011. Mumbai, Maharasthra: Indian Academy of Pediatrics; 2011. p. 88-93.
HPV and cervical cancer-prospect for prevention through vaccination. Indian J Med Pediatr Oncol 2005;26(1): 20-23.
Summary Report on HPV and Cervical cancer statistics in India 2007 [cited 2008 May 1].
Papillomaviruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.
HPV IARC monograph summary. Lancet Oncol 2005;6:204.
Genital human papillomavirus infection. Clin Infect Dis 2006;43:624-629.
Comparison of human papillomavirus types 16, 18 and 6 capsid antibody responses following incident infection. J Infect Dis 2000 Jun;181(6):1911-1919.
Human papillomavirus and cervical cancer. Lancet 2007 Sep 8;370(9590):890-907.
Cofactors in human papillomavirus carcinogenesis. Role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;(31):20-28.
Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Philadelphia, PA: WB Saunders; 2013. Chapter 5. p. 310-312.
Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006 Jun 22;354(25):2645-2654.
Cervical-cancer screening beyond 2000. Lancet Oncol 2001 Jan;2(1):27-32.
Human papillomavirus and vaccination. Mayo Clin Proc 2008 Jun;83(6):701-706.
1st ed. Immunization, Vaccine and Biological World Health Organization; 2009.
Consensus recommendations on immunization. Indian Pediatr 2008 Aug;45(8):635-648.
Centers for disease control and prevention (CDC); Advisory committee onImmunization Practices (ACIP). Quadrivalent Human Pappilomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 Mar 23;56(RR-2):1-24.
Indian HPV Vaccine Study Group. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women. J Obstet Gynaecol Res 2010 Feb;36(1):123-132.
Prevention strategies against the human papillomavirus: the effectiveness of vaccination. Gynecol Oncol 2007 Nov; 107(2 Suppl 1):S19-S23.
2003 (April). Swedish National Control study. (2006-2010).
Safety, efficacy and immunogenicity of quadrivalent HPV vaccine (Gardasil) in women aged 24-45. Presented at 24th International Papillomavirus Congress, November 3-9, 2007, Beijing [abstract PA1-04].
HPV vaccines. In: Plotkin SA, Orenstein WA, editors. Vaccines. 5th ed. Philadelphia: Saunders; 2008. p. 243-277.
Correlating immunity with protection for HPV infection. Int J Infect Dis 2007 Nov;11(Suppl 2):S10-S16.
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin 2009 Oct;5(10):705-719.
Human papilloma virus vaccines and current controversy. Indian Pediatr 2011 Mar;48(3):248-249.

PDF Share